STABLE FAT-SOLUBLE VITAMIN POWDERS

Information

  • Patent Application
  • 20230091169
  • Publication Number
    20230091169
  • Date Filed
    February 17, 2021
    3 years ago
  • Date Published
    March 23, 2023
    a year ago
  • CPC
    • A23L33/15
    • A23L29/35
    • A23L27/33
    • A23L7/198
    • A23L7/196
  • International Classifications
    • A23L33/15
    • A23L29/30
    • A23L27/30
    • A23L7/10
    • A23L7/196
Abstract
Stable vitamin A powders The present invention relates to BHT-free powderous formulations comprising a fat-soluble-vitamin or a carotenoid, a hydrocolloid, a starch hydrolysate, tocopherol and sodium ascorbate and its use for staple food fortification.
Description

The synthetic antioxidant BHT (butyl hydroxy toluene) has a negative reputation both from a health and an environmental perspective. Therefore, substitution of BHT with alternative antioxidants is targeted to provide sustainable vitamin A powder products with state-of-the-art performance. Staple foods such as oil, flour, sugar, rice and condiments are fortified with vitamin A. Vitamin A powders are used for fortifying e.g. flour and sugar. The test conditions in the accelerated tests used for approving a vitamin A powder for flour or sugar application are very harsh. Until now only vitamin A powders containing the very effective antioxidant BHT were able to pass the tests. Currently all vitamin A powders on the market intended for flour or sugar fortification contain BHT.


The present invention relates to stable fat-soluble vitamin or carotenoid powders not containing BHT but still having similar stability in flour and sugar premixes stored under accelerated conditions as current BHT-containing products for these applications.


It was surprisingly found, that a combination of sodium-ascorbate and tocopherol (DL-α-tocopherol or natural mixed tocopherol) as antioxidants in a powder formulation comprising a fat-soluble vitamin or a carotenoid, a hydrocolloid and a starch hydrolysate provided similar stability in flour and sugar premix stored under accelerated conditions as current commercial products containing BHT.


It was not to be foreseen by the person skilled in the art that a combination of sodium-ascorbate and tocopherol according to the present invention and the use of it would solve above mentioned issues.


According to the invention the content of said at least one fat-soluble vitamin and/or carotenoid is from 0.25 to 25 wt.-% of the formulation.


Examples of carotenoids are β-carotene, lutein, lutein ester or lycopene and mixtures thereof.


Examples of fat-soluble vitamins are vitamin A, vitamin D, Vitamin K and/or its derivatives or mixtures thereof. Preferred is vitamin A and/or its derivative, more preferred vitamin A esters and here especially the vitamin A palmitate.


According to the invention the content of vitamin-A esters is from 5 to 25 wt.-% of the formulation, preferably from 10 to 22 wt.-%, more preferably from 12 to 20 wt.-% of the total weight of the powderous formulation. The preferred vitamin A ester is vitamin A palmitate.


As a further component of the powderous formulation of the invention it comprises a combination of two antioxidants sodium ascorbate and tocopherol, whereby the term tocopherol encompasses DL-α-tocopherol and mixed tocopherol and whereby the weight-ratio of sodium ascorbate to tocopherol is between 1 and 6, preferably between 1.5 and 6. The content of sodium-ascorbate and tocopherol on the formulation is from 0.75 to 12 wt.-% of the formulation, preferably from 2 to 8 wt.-%, more preferably from 2 to 4 wt.-%.


The powderous formulation contains further a hydrocolloid as emulsifier and matrix component.


According to the invention the content of said at least one hydrocolloid is from 9.25 to 25 wt.-% of the formulation, preferably from 10 to 22 wt.-%, more preferably from 12-20 wt.-% of the total weight of the powderous formulation.


Examples of hydrocolloids are polysaccharides, gelatin of low bloom, medium bloom or high bloom from fish, pork or bovine, caseines/caseinates and other proteinaceous hydrocolloids.


Preferred according to the invention are polysaccharides.


The term polysaccharide as used herein includes xanthan gum, gum acacia, pectin, guar gum, caroub gum, alginates, celluloses, cellulose derivatives, such as starch and starch derivatives. Preferred polysaccharides according to the present invention are gum acacia, starch, starch derivatives; especially preferred are gelatinized starch and modified food starch and here particularly preferred are modified food starches.


The term “modified food starch” as used herein relates to modified starches that are made from starches substituted by known chemical methods with hydrophobic moieties. For example starch may be treated with cyclic dicarboxylic acid anhydrides such as succinic and/or glutaric anhydrides, substituted with an alkyl or alkenyl hydrocarbon group.


A preferred modified starch is starch sodium octenyl succinate (OSA-starch). OSA-starch as used herein denotes any starch (from any natural source such as corn, wheat, tapioca, potato or synthesized) that was treated with octenyl succinic anhydride. The degree of substitution, i.e. the number of esterified hydroxyl groups with regard to the total number of hydroxyl groups usually varies in a range of from 0.1% to 10%, preferably in a range of from 0.5% to 5%, more preferably in a range of from 2% to 4%.


OSA-starch is commercially available e.g. from Ingredion under the trade names HiCap 100, Capsul HF, Capsul HS, Purity Gum 2000, UNI-PURE, HYLON VII from Roquette Freres; from Cargill under the trade name C*EmCap or from Tate & Lyle. HiCap 100, Capsul HF and Capsul HS are especially preferred, mostly preferred are Capsul HF and Capsul HS.


A further component of the formulation according to the present invention are the “starch hydrolysates”, which as used herein denote dextrins, maltodextrins and glucose syrup and have the function as matrix component and plasticizer. Preferred are starch hydrolysates with a DE-value of 10 to 30, more preferred are hydrolysates with a DE-value of 15 to 25, most preferred are hydrolysates with a DE-value of 17 to 20.


The DE-value characterizes the reducing capacity based on the reducing capacity of anhydrous dextrose and is determined by the DIN 10 308 method, edition 5.71, of the Deutsche Normenausschuss Lebensmittel and landwirtschaftliche Produkte.


According to the invention the content of said at least one starch hydrolysate is from 20 to 89.75 wt.-% of the formulation, preferably from 25 to 78 wt.-%, more preferably from 30 to 74 wt.-% of the total weight of the powderous formulation.


The powderous formulation according to the invention may further contain, depending on the drying process additional constituents such as i) native starches as a powdering agent and ii) anti-caking agents, e.g. tri-calcium phosphate and silicates, such as silicon dioxide or sodium aluminium silicate, which embed the powders according to the invention and which content in total is from 0 to 50% of the total weight of the powder. Furthermore carrier oil such as sunflower oil, corn oil, MCT oil (medium chain triglycerides) or other vegetable oils are optionally present in the formulation in an amount of 0 to 20% of the total weight of the powder. Residual water (residual humidity) which content in total is 0 to 5% of the total weight of the powder can also be present in the powder after the drying process.


The invention is further illustrated by the following examples.







EXAMPLES

Measuring Stability of the Vitamin-A palmitate formulation in flour (Flour Test, Based on USAID—Moist Flour Test CSB13)


Mix 0.2 g vitamin A palmitate powder produced ac to example 1-14 with 5 g flour having a moisture content of 13.5 to 14.5%. Store the mixture in a closed vial at 45° C. for 21 days. Analyse the vitamin A content in the mixture at time point zero (initial value) and after 10 and 21 days of storage. Use one vial for each single determination. Calculate the remaining vitamin A in percentages of the initial value at each time point.


Measuring stability of the vitamin-A palmitate formulation in sugar (sugar premix ad modum INCAP (Instituto Nutricion Centro America y Panama).)


Prepare the following blends:

    • 1) Sugar blend: 22 g vitamin A palmitate powder produced according to example 1 to 14 and 75 g sucrose.
    • 2) Antioxidant/oil blend: 160 mg Grindox® 1020 and 29.76 g coconut oil heated to 37° C.


Sugar Premix:

Take out 1.49 g of the antioxidant/oil blend and mix it into the sugar blend. Mix until the oil is evenly distributed throughout the sugar. Store the sugar premix in PE-bags at 40° C./75% RH for 3 months. Analyse the vitamin A content at time point zero (initial value) and after 1, 2 and 3 months storage. Calculate the remaining vitamin A in percentages of the initial value at each time point.


Example 1

600 g Capsul HS, 1479 g Glucidex 19 and 78 g sodium ascorbate were dissolved during stirring in 1430 g of water at 60-65° C. A mixture of 600 g vitamin A palmitate oil (1.7 Mio IU/g) and 27 g D,L-α-tocopherol was added to the aqueous solution during stirring and emulsified until the average oil droplet size d(0.5) was less than 1 μm (measured by Malvern Mastersizer 3000). The viscosity was adjusted with water and the emulsion was sprayed into native corn starch (powdering agent) containing tricalcium phosphate (TCP) (anti-caking agent). The formed particles were dried in air at 25-150° C. until the water content in the powder was below 5%.


The powder produced according to example 1 had the following composition [weight-%]:


















Maltodextrin
46.4



Modified food starch
18.8



Vitamin A palmitate (1.7 Mio IU/g)
18.8



Sodium ascorbate
2.4



DL-α-tocopherol
0.8



Corn starch + TCP
8.0



Residual water (residual humidity)
4.8










The examples 2 to 5 (Table 1) were produced according to example 1, with the exception that the DL-α-tocopherol amount was kept constant, while the sodium ascorbate amount was reduced.












TABLE 1








Weight ratio sodium-



sodium

ascorbate to DL-α-


Example
ascorbate [g]
DL-α-tocopherol
tocopherol


















1
78
27
2.,89


2
60
27
2.22


3
30
27
1.11


4
15
27
0.56


5
0
27
0.0









The products produced according to examples 1-5 were tested in the flour test (Table 2) and in the sugar premix test (Table 3). Commercial vitamin A palmitate products stabilized with BHT were used as references in the tests















TABLE 2








Weight ratio








sodium-
Initial
10 days
21 days



sodium-
DL-α-
ascorbate
[%
[%
[%



ascorbate
tocopherol
to DL-α-
remaining
remaining
remaining


Example
[g]
[g]
tocopherol
of initial]
of initial]
of initial]





















1
78
27
2.89
100
93
87


2
60
27
2.22
100
88
86


3
30
27
1.11
100
93
77


4
15
27
0.56
100
89
37


5
0
27

100
34
18










Reference: Commercial vitamin A palmitate
100
91
82


250 containing BHT from BASF























TABLE 3








Weight ratio









sodium-
Initial
1 month
2 months
3 months



sodium-
DL-α-
ascorbate
[%
[%
[%
[%



ascorbate
tocopherol
to DL-α-
remaining
remaining
remaining
remaining


Example
[g]
[g]
tocopherol
of initial]
of initial]
of initial]
of initial]






















1
78
27
2.89
100
90
83
73


2
60
27
2.22
100
88
83
60


3
30
27
1.11
100
89
66
38


4
15
27
0.56
100
76
47
N/A


5
0
27

100
64
43
N/A











Reference: Commercial vitamin A palmitate
100
80
73
61


250 containing BHT from BASF









Table 2 and 3 show that a combination of DL-α-tocopherol and sodium-ascorbate increases the stability of the vitamin-A palmitate-formulation in the flour and in the sugar premix. Furthermore, with this antioxidant combination it is possible to make a formulation with similar stability in flour and sugar premix as the current commercially available BHT-containing formulation.


Example 6

600 g Capsul HS, 1479 g Glucidex 19 and 60 g sodium ascorbate were dissolved in 1430 g of water at 60-65° C. during stirring. A mixture of 600 g vitamin A palmitate oil (1.7 Mio IU/g) and 39 g Covi-Ox-T-70 mixed tocopherols, 70% concentrate) was added to the aqueous solution during stirring and emulsified until the average oil droplet size d(0.5) was less than 1 μm (measured by Malvern Mastersizer 3000). The viscosity was adjusted with water and the emulsion was sprayed into native corn starch (powdering agent) containing tricalcium phosphate (TCP) (anti-caking agent). The formed particles were dried in air at 25-150° C. until the water content in the powder was below 5%.


The powder produced according to example 6 had the following composition [weight-%]:


















Maltodextrin
49.6



Modified food starch
20.0



Vitamin A palmitate (1.7 Mio IU/g)
20.0



Sodium ascorbate
2.0



Mixed-tocopherol, 70% concentrate
1.3



Corn starch + TCP
2.2



Residual water (residual humidity)
4.9










The examples 7 to 10 (Table 4) were produced according to example 6, with the exception that the mixed-tocopherol amount was kept constant, while the sodium ascorbate amount was reduced.














TABLE 4








sodium
mixed-tocopherol
Weight ratio sodium-




ascorbate
(70% concentrate)
ascorbate to mixed-



Example
[g]
[g]
tocopherol (100%)





















6
60
39
2.2



7
45
39
1.65



8
30
39
1.10



9
15
39
0.55



10
0
39
0.0










The products produced according to examples 6-10 were tested in the flour test (Table 5) and in the sugar premix test (Table 6). Commercial vitamin A palmitate products stabilized with BHT were used as references in the tests.















TABLE 5








Weight ratio








sodium-




mixed
ascorbate
Initial
10 days
21 days



Sodium
tocopherol
to mixed
[%
[%
[%



ascorbate
(70%)
tocopherol
remaining
remaining
remaining


Example
[g]
[g]
(“100%”)
of initial]
of initial]
of initial]





















6
60
39
2.2
100
89
84


7
45
39
1.65
100
87
86


8
30
39
1.10
100
92
80


9
15
39
0.55
100
90
72


10
0
39

100
57
37










Reference: Commercial VAP
100
91
82


250 containing BHT from BASF























TABLE 6








Weight ratio









sodium-




Mixed
ascorbate
Initial
1 month
2 months
3 months



Sodium
tocopherol
to mixed
[%
[%
[%
[%



ascorbate
(70%)
tocopherol
remaining
remaining
remaining
remaining


Example
[g]
[g]
(“100”)
of initial]
of initial]
of initial]
of initial]






















6
60
39
2.2
100
86
81
66


7
45
39
1.65
100
87
83
55


8
30
39
1.10
100
87
57
42


9
15
39
0.55
100
82
52
N/A


10
0
39

100
49
39
N/A











Reference: Commercial vitamin A palmitate
100
80
73
61


250 containing BHT from BASF









Table 5 and 6 show that a combination of mixed tocopherols and sodium ascorbate increases the stability of the vitamin A palmitate formulation in the flour and in the sugar premix. Furthermore, with this antioxidant combination it is possible to make a formulation with similar stability in flour and sugar premix as the current commercially available BHT-containing formulation.


Example 11

600 g Capsul HS, 1766 g Glucidex 19 and 78 g sodium ascorbate were dissolved in 1430 g of water at 60-65° C. during stirring. A mixture of 600 g vitamin A palmitate oil (1.7 Mio IU/g) and 40.5 g DL-α-tocopherol was added to the aqueous solution during stirring and emulsified until the average oil droplet size d(0.5) was less than 1 μm (measured by Malvern Mastersizer 3000). The viscosity was adjusted with water and the emulsion was sprayed into native corn starch (powdering agent) containing tricalcium phosphate (TCP) (anti-caking agent). The formed particles were dried in air at 25-150° C. until the water content in the powder was below 5%.


The powder produced according to example 11 had the following composition [weight-%]:


















Maltodextrin
52.3



Modified food starch
17.8



Vitamin A palmitate (1.7 Mio IU/g)
17.8



Sodium ascorbate
2.3



DL-α-tocopherol
1.2



Corn starch + TCP
4.0



Residual water
4.6










The examples 12 to 14 (Table 7) were produced according to example 11, with the exception that the sodium ascorbate amount was kept constant, while the DL-α-tocopherol amount was reduced.












TABLE 7








Weight ratio sodium-



sodium

ascorbate to DL-α-


Example
ascorbate [g]
DL-α-tocopherol
tocopherol


















11
78
40.5
1.93


12
78
27
2.89


13
78
13.5
5.78


14
78
0
N/A









The products produced according to example 5 and 11 to 14 were tested in the flour test (Table 8) and in the sugar premix test (Table 9). Commercial vitamin A palmitate products stabilized with BHT were used as references in the tests.















TABLE 8








Weight ratio








sodium-
Initial
10 days
21 days



sodium-
DL-α
ascorbate
[%
[%
[%



ascorbate
tocopherol
to DL-α
remaining
remaining
remaining


Example
[g]
[g]
tocopherol
of initial]
of initial]
of initial]





















11
78
40.5
1.93
100
88
81


12
78
27
2.89
100
90
85


13
78
13.5
5.78
100
92
87


14
78
0
N/A
100
50
24


5
0
27
N/A
100
34
18










Reference: Commercial vitamin A palmitate
100
91
82


250 containing BHT from BASF























TABLE 9








Weight ratio









sodium-
Initial
1 month
2 months
3 months



sodium-
DL-α-
ascorbate
[%
[%
[%
[%



ascorbate
tocopherol
to DL-α-
remaining
remaining
remaining
remaining


Example
[g]
[g]
tocopherol
of initial]
of initial]
of initial]
of initial]






















11
78
40.5
1.93
100
87
79
53


12
78
27
2.89
100
87
85
66


13
78
13.5
5.78
100
90
84
66


14
78
0
N/A
100
63
40
26


5
0
27
N/A
100
64
43
N/A











Reference: Commercial vitamin A palmitate
100
80
73
61


250 containing BHT from BASF








Claims
  • 1.-15. (canceled)
  • 16. Powderous BHT-free formulation comprising a fat-soluble vitamin or a carotenoid, a hydrocolloid, a starch hydrolysate, tocopherol and sodium ascorbate optionally a mixture of powdering- and anti-caking agent, optionally a carrier oil and optionally residual water.
  • 17. Powderous BHT-free formulation comprising 0.25 to 25 wt.-% of total weight of the powder of a fat soluble vitamin or a carotenoid, 9.25 to 25 wt.-% of total weight of the powder of a hydrocolloid, 20 to 89.75 wt.-% of total weight of the powder of a starch hydrolysate and 0.75 to 12 wt.-% of total weight of the powder of tocopherol and sodium ascorbate, 0 to 20 wt.-% of total weight of the powder of carrier oil, 0 to 50 wt.-% of total weight of the powder of a mixture of powdering and anti-caking agent and 0 to 5 wt.-% of total weight of the powder of residual water.
  • 18. Formulation according to claim 16, whereby the fat-soluble vitamin is selected from the group consisting of vitamin A and/or its derivatives, vitamin D and/or its derivatives, and vitamin K and/or its derivatives.
  • 19. Formulation according to claim 16, whereby the carotenoid is selected from the group consisting of β-carotene, lutein, lutein ester or lycopene and mixtures thereof.
  • 20. Formulation according to claim 18, whereby the fat-soluble vitamin is selected from vitamin A and/or its derivatives.
  • 21. Formulation according to claim 20, whereby the fat-soluble vitamin is vitamin A palmitate.
  • 22. Formulation according to claim 16, whereby the hydrocolloid is selected from polysaccharides.
  • 23. Formulation according to claim 22, whereby the polysaccharide is selected from the group consisting of xanthan gum, acacia gum, pectin, guar gum, caroub gum, alginate, cellulose, cellulose derivatives, starch, starch derivatives and modified food starch.
  • 24. Formulation according to claim 23, whereby the modified food starch is starch sodium octenyl succinate.
  • 25. Formulation according to claim 16, whereby the starch hydrolysate has a DE-value of 10 to 30.
  • 26. Formulation according to claim 25, whereby the starch hydrolysate has a DE-value of 15 to 25.
  • 27. Formulation according to claim 25, whereby the starch hydrolysate has a DE-value of 17 to 20.
  • 28. Formulation according to claim 16, whereby the weight ratio of sodium ascorbate to tocopherol is between 1 and 6.
  • 29. A method comprising adding the formulation according to claim 16 to a staple food, resulting in staple food fortification.
  • 30. The method according to claim 29 whereby the staple food fortification is a flour, sugar, rice, or condiment.
  • 31. Formulation according to claim 16, whereby the weight ratio of sodium ascorbate to tocopherol is between 1.5 and 6.
Priority Claims (1)
Number Date Country Kind
20157973.7 Feb 2020 EP regional
PCT Information
Filing Document Filing Date Country Kind
PCT/EP2021/053827 2/17/2021 WO